300364.SZ
300364.SZ
CNE100001XD9
COL
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 42/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves approx. 1.4x as much as the broader market.

Beta (Market Relation)
1.37x
Above average
Volatility (5Y p.a.)
80.2% p.a.
5-Year Horizon
Max Drawdown (5Y)
-64.8%
5-Year Horizon
Sharpe Ratio
0.39
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -13.2%
3 Years 78.8% -56.3% 0.22 +19.8%
5 Years 80.2% -64.8% 0.39 +33.9%
10 Years 67.3% -85.3% 0 +2.6%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
🔴 High valuation risk: Avg P/E of 97.8 (Elevated multiple compression risk)
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (80.2% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -85.3% in the extended horizon.
ende